A confident woman in her 30s navigating her GLP-1 journey with clarity and strength
The clinical data behind why most GLP-1 results don't last.

67% of women
regain the weight.
The other 33% do something different.

This 3-minute quiz calculates your specific risk factors — muscle loss rate, metabolic adaptation score, and hormonal context — based on your medication, dose, and timeline. (Wilding et al. 2022, STEP 1 Extension Trial)

NASM Weight Loss Specialist (WLS)  ·  NASM Nutrition Coach (NC)  ·  MIT Artificial Intelligence (AI) Certified

Limited to 20 personalized plans per week to maintain coaching quality.
CALCULATE YOUR RISK SCORE →

3 minutes · Free · No card required

33M+ Americans on GLP-1 medications and growing
67% In the STEP 1 extension study, participants regained about two-thirds of prior weight loss after stopping semaglutide and lifestyle intervention. Wilding et al. 2022, STEP 1
4× Rebound velocity when the shield drops without a metabolic foundation

You're not imagining this.

You finally found a tool that worked.
But a new fear replaced it.

It is the heartbreaking realization that doing everything "right" still leaves you terrified. You finally found the tool that worked when nothing else did, but now you're facing a new kind of fear — the constant chill, the profound exhaustion, the dread of the next injection, and the quiet panic of wondering what happens if the medication stops.

You're not imagining this. Syntra doesn't just support the journey. It protects what makes the destination worth it — your strength, your energy, and the woman you're becoming.

CALCULATE YOUR RISK SCORE →

The data nobody shares at the pharmacy.

Right now, the medication is
an Artificial Shield.

It is doing the heavy lifting — suppressing the hunger signals and metabolic responses that used to dominate your day. But underneath that pharmaceutical shield, your natural metabolic engines are powering down. Here is what the prescription pad doesn't say:

67%

In the STEP 1 extension study, participants regained about two-thirds of prior weight loss after stopping semaglutide and lifestyle intervention.

Wilding et al. 2022, STEP 1 Extension Trial

4×

rebound velocity in hunger and cravings once the shield lifts

without a protected metabolic foundation

Loss of lean muscle, hormonal disruption, crashing metabolic rate

while the scale moves in the right direction

CALCULATE YOUR RISK SCORE →

3 minutes · Free · No card required

The solution

A personalized 30-day protocol
built to fix this.

To fix this, we built a personalized 30-day metabolic protocol. This is the only way to neutralize the severe metabolic starvation so you don't lose yourself today or rebound tomorrow. It rebuilds the metabolic foundation from the ground up — and provides an absolute exit strategy for when you're ready.

CALCULATE YOUR RISK SCORE →

3 minutes · Free · No card required

Backed by science. Built for you.

Syntra was developed by Ivan Duran
to protect the body's foundation.

Using elite human performance strategies built on peer-reviewed GLP-1 outcome research and injection-day timing methodology. The framework is grounded in published science — not assumptions about what should work.

NASM Weight Loss Specialist (WLS)
NASM Nutrition Coach (NC)
MIT Artificial Intelligence (AI) Certified
CALCULATE YOUR RISK SCORE →

3 minutes · Free · No card required

"Syntra doesn't just support the journey. It protects what makes the destination worth it — your strength, your energy, and the woman you're becoming."
— SYNTRA PROTOCOL

Don't wait until the shield drops.

Discover what your body really needs
to protect the results.

Start the 3-minute quiz. Unlock a personalized blueprint built for exactly where you are right now — your medication, your week, your symptoms.

CALCULATE YOUR RISK SCORE →

3 minutes · Free · No card required